anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,387
Current window 9,751-9,780
Pages 3,680
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

9,751-9,780 of 110,387

filter-aware
08
The slide uses a process flow diagram to map specific pain points to development, regulation, reimbursement, and adoption stages.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
CDx = co-diagnostics; Source: Stakeholder interviews, workshops and Deloitte analysisAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
The slide uses a simple list-based framework to categorize 12 items into 3 groups of 4.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The diagram uses a flow-chart style to represent iterative loops and parallel processes within the pharmaceutical lifecycle.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
16
The slide uses a process flow diagram to map the medical device lifecycle, highlighting key milestones like NICE routing and local patient access.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
17
The slide uses a complex flow diagram to represent the regulatory and adoption pathway, mapping stages to time durations.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
The slide uses a two-part framework (A and B) to define the scope of the analysis.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
21
The slide uses a process-flow framework to categorize specific barriers alongside cross-cutting organizational challenges.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
23
The slide uses a complex flow diagram to differentiate development paths for three drug types.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
24
The slide uses a simple icon-based list structure to present qualitative findings from stakeholder interviews.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
26
The slide uses a 2x2 grid layout to categorize stakeholder feedback.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
28
The slide uses a color-coded flow chart to distinguish between different product types (small molecules, biologics, vaccines) and their respective regulatory routes.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
29
The slide uses a process-like icon header to indicate the regulatory stage.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
31
Uses a 2x2 grid layout to contrast different stakeholder viewpoints on regulatory processes.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
33
The slide uses a color-coded flow chart to distinguish between different drug types and their respective evaluation processes (NICE vs. Commissioning).Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
34
The slide uses a list-based structure to detail specific industry-public sector friction points.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
35
Uses a hub-and-spoke diagram to connect stakeholder quotes to a central figure representing the patient or the system.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
36
The slide uses a 2x2 matrix layout to contrast different stakeholder groups.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
39
The slide uses a list-based structure to detail specific pain points identified through research.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
41
The slide uses a 2x2 grid layout to contrast different stakeholder viewpoints.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
43
The slide uses a three-column layout to structure the case study narrative.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
45
The slide uses a process flow diagram to map specific pain points to development, regulation, reimbursement, and adoption stages.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
48
Accelerated Access Review UK MappingAccelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
49
Uses a hub-and-spoke diagram to connect stakeholder quotes to a central user icon, with color-coding for different stakeholder groups.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
50
The slide uses a 2x2 grid layout to contrast different stakeholder viewpoints.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
52
The slide uses a color-coded line system to represent different regulatory paths based on device classification.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
53
The slide uses a process-like header indicating this is part of a larger regulatory journey.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
54
The slide uses color-coded speech bubbles to attribute quotes to different stakeholder groups (Industry, NHS, Charities, HMG/ALBs).Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
55
Uses a 2x2 grid layout to contrast different stakeholder viewpoints.Accelerated Access Review UK Mapping · Deloitte
Consulting deck Strategy consulting Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit